160 drugs transferred out of health insurance (with list)

160 drugs, transferred out of medical insurance On August 3, Anhui Provincial Health Insurance Bureau issued a provincial supplement to Class B drugs 2020 digestive drugs public announcement.
documents show that, in accordance with the Notice of the Ministry of Human Resources and Social Security of the State Health Insurance Administration on the Publication of the National List of Essential Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drugs, "the class B drugs added to the original provincial drug catalogue shall be gradually digested within three years." "
" requirements, on the basis of full consideration of the drug habits of the insured people, according to the anhui Province pharmaceutical centralized procurement platform procurement data, the provincial health insurance bureau has drawn up 2020 to digest drugs, is now public: a total of 160 drugs in 2020 was transferred out of Anhui Province health insurance, including: 1, not in the provincial drug collection platform online procurement of 58 drugs 2, 2017-2019 three-year provincial drug harvesting platform procurement volume is "0" of the drug 87 3, 2019 procurement volume of "0" of the drug 15 in Anhui Province in 2020 transferred varieties, a total of 91 Western medicine, 61 Chinese medicine and 8 ethnic medicine.
Cypress blue combing found that, including Remosjong injection, Zanamiwe inhaler, Gyeongtamol slow release control agent type and other Western medicine, rib capsule capsules, golden hedgehog nine positive agents, etc. , are due to 19 years of procurement volume of 0 was immediately transferred out of the health insurance directory.
In addition, Western medicines such as cephalosporine bartan injections, cephalosporine Shubatan injections, ashuriverwe, daratave, compound ammonium glyphosate injections, azithromycin oral dispersals, chrysanthemum anti-flu capsules, Yan Corning pills, Sichuan Bay Sydney paste, sleeping to supplement the brain oral solution and other traditional Chinese medicine, such as treasure pills, Ansin town 20 flavor pills, sassin cough soup scattered and other ethnic drugs, because the three-year procurement volume of 0 was transferred out of the health insurance directory.
, the State Health Insurance Administration issued a notice requiring the end of June to remove the state's key monitoring varieties from the catalog, and complete the digestion of 40% of provincial varieties.
To this, Seber blue learned that the local supplementary catalog in accordance with the principle of 442 in three years to digest the completion, but did not introduce specific standards and rules;
In fact, many provinces transferred out of the product, some are already relatively thin profit margins, abandoned shell products, or even only the approval number, this Anhui Province transferred out, but also most of these products - in a longer period of time there is no purchase volume.
provinces to add varieties, the opportunity to come according to fengyun medicine talk statistics, before 19 provinces have carried out the transfer of additional varieties, in addition to the following 17 provinces, there are Henan Province and Hunan Province.
(picture source: Fengyun medicine talk exclusive finishing) from the above-mentioned provinces to adjust the situation, the provinces have basically achieved the focus of monitoring varieties to take the lead in transferring out of health insurance, but the specific size of varieties and the corresponding time nodes have some differences.
the local supplement of the varieties in the medical insurance catalogue, requiring the transfer of the catalogue in batches within three years, the proportion of three-year clean-up varieties is 40%, 40%, 20%, the next two years the adjustment of varieties in the provinces will become very critical.
for provincial supplements, the next two years will either be successfully transferred to the national health-care directory, or leave the health-care channels, open up new markets, and take the path of zero out-of-pocket or retail.
the release of the new document, the provincial supplements have also ushered in the opportunity to enter the national health insurance directory.
yesterday, the State Health Insurance Administration issued the 2020 National Health Insurance Drug Catalog Adjustment Work Programme (Draft for Comments), to determine the scope of a new round of medical insurance transfer, transfer out of the variety.
, the document specifically states that among the proposed new drugs in the 2020 drug catalogue: by December 31, 2019, five or more provincial-level latest versions of the list of medical insurance drugs will be entered.
, the main active ingredients were included in the "first batch of national key monitoring of rational drug use drug catalog" except.
to some extent, if a variety appears in more than five provincial supplemental catalogues by December 31, 2019, it will have a chance to enter the 2020 National Health Insurance Drug Catalog as long as it is not a priority monitoring variety.
previously combed by Mi Net, in 2019, China's public medical institutions terminal 37 more than one billion yuan of local health insurance catalog varieties, there are 35 varieties of provinces to add more than 5 varieties.
Among them, excluding the key monitoring varieties, dizosin injection, injection with sorpenquine, injection of cephalosporine sodium terabytes, hydrochloric acid polyzobi star lipid body injection, injection with yew alcohol lipids, injection with five-water cephalosporine sodium, puddi blue anti-inflammatory oral solution, injection of cephalosporine sodium, injection with rebera Sodium pyridoline, injection of cephalosporine sodium, injection of cyclophosphate glucosamine, injection of cephalosporine sodium Shubatan sodium, large strains of red king day injection, radon chloretamine tablets, injection of cephalosporine sodium and other varieties, additional provinces are more than 5, or have the opportunity to enter the 2020 version of national health insurance.
There are also these varieties, the opportunity to enter the National Health Insurance yesterday documents show that included in the clinical urgent need for new drugs abroad list, encourage generic drugs catalog or encourage research and development to declare the list of children's drugs, and before December 31, 2019 by the State Drug Administration approved the listing of drugs, into the scope of adjustment.
the following varieties, it is possible to enter the 2020 health insurance list.
(Photo source: Fengyun Medicine) In addition, in the second batch of national collection, Anli Shengtan, injection of yew alcohol (albumin binding type), tadarafei and other non-included in the national health insurance directory of self-funded varieties, also entered the scope of the adjustment of the varieties of the health insurance catalogue.
There have been research institutions believe that the draft continues to reflect the support and good for innovative drugs, the future can meet clinical needs, the efficacy of accurate, high clinical value of innovative drugs will continue to be favored by health insurance, while the annual dynamic adjustment mechanism will help innovative drugs approved to market faster into health insurance payments.
In addition, allowing medical institutions to bargain during the renewal period of health insurance will further assist in the release of innovative drugs, as the gradient price reduction covers patients with different stages of the ability to pay for innovative drugs from strong to weak, and the impact on the industry is also far-reaching.
.